Avicanna Inc. ( AVCNF) - Stock Earnings
AVCNF Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2021Q3 | -2.7 million CAD | 987970 CAD |
| 2021Q4 | -4.1 million CAD | 1.2 million CAD |
| 2022Q1 | -939080 CAD | 1.0 million CAD |
AVCNF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2019 | -21.1 million CAD | 168250 CAD |
| 2021 | -12.6 million USD | 3.3 million USD |
| 2025 Est. | — | — |
AVCNF
Price: $0.09
52 week price:
Earnings Per Share: -0.02 USD
P/E Ratio: -6.85
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 11.8 million